Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole exhaled breath pharmacokinetic study in cystic fibrosis
2018-002579-16Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of posaconazole in aspergillosis and cystic fibrosis (CF), sponsored by Karolinska University Hospital. Started Jul 2018; status: active.
02
Drugs
posaconazole
03
Conditions
aspergillosiscystic fibrosis (CF)
Beyond the preview
Go deeper on 2018-002579-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002579-16.